Cargando…

Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial

BACKGROUND: Cervical cancer is caused by Human Papilloma viruses (HPV) and is preceded by precursor stages: Cervical Intraepithelial Neoplasia (CIN). CIN is mostly found in women in their reproductive age and treated with a Loop Electrosurgical Excision Procedure (LEEP). The recurrence or residual d...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Laar, R. L. O., Hofhuis, W., Duijnhoven, R. G., Polinder, S., Melchers, W. J. G., van Kemenade, F. J., Bekkers, R. L. M., Van Beekhuizen, H. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285539/ https://www.ncbi.nlm.nih.gov/pubmed/32517663 http://dx.doi.org/10.1186/s12885-020-07025-7

Ejemplares similares

HPV vaccination to prevent recurrence of anal intraepithelial neoplasia in HIV+ MSM
por: Gosens, Karien C.M., et al.
Publicado: (2021)

Cervical intraepithelial neoplasia and the risk of spontaneous preterm birth: A Dutch population-based cohort study with 45,259 pregnancy outcomes
por: Loopik, Diede L., et al.
Publicado: (2021)

TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial
por: van de Sande, A. J. M., et al.
Publicado: (2018)

A second generation cervico-vaginal lavage device shows similar performance as its preceding version with respect to DNA yield and HPV DNA results
por: Verhoef, Viola MJ, et al.
Publicado: (2013)

Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
por: Inturrisi, Federica, et al.
Publicado: (2021)

Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities
por: de Bie, R P, et al.
Publicado: (2009)

HPV Vaccination as Adjuvant to Conization in Women with Cervical Intraepithelial Neoplasia: A Study under Real-Life Conditions
por: del Pino, Marta, et al.
Publicado: (2020)

Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia – A case series
por: Wouters, Tirza, et al.
Publicado: (2019)

Sexual Behaviour and HPV Infections in 18 to 29 Year Old Women in the Pre-Vaccine Era in the Netherlands
por: Lenselink, Charlotte H., et al.
Publicado: (2008)

Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening
por: Verhoef, Lisanne, et al.
Publicado: (2023)

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV‐positive women: Results from a Dutch primary HPV‐based screening cohort
por: Verhoef, Lisanne, et al.
Publicado: (2021)

Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
por: Daayana, S, et al.
Publicado: (2010)

Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy
por: Aitken, Clare A., et al.
Publicado: (2019)

Assessing the risk of cervical neoplasia in the post‐HPV vaccination era
por: Lehtinen, Matti, et al.
Publicado: (2022)

DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women
por: Boers, A, et al.
Publicado: (2014)

Quantitative Proteomic Analysis of MCM3 in ThinPrep Samples of Patients with Cervical Preinvasive Cancer
por: Köse, Büşra, et al.
Publicado: (2023)

Marijuana use and cervical HPV/neoplasia
por: D'Souza, G, et al.
Publicado: (2009)

Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children
por: Van Buynder, P. G., et al.
Publicado: (2010)

Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females
por: van der Weele, Pascal, et al.
Publicado: (2019)

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
por: Bulk, S, et al.
Publicado: (2006)

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination
por: Langerak, T., et al.
Publicado: (2022)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

To vaccinate or not to vaccinate? Perspectives on HPV vaccination among girls, boys, and parents in the Netherlands: a Q-methodological study
por: Patty, Nathalie J. S., et al.
Publicado: (2017)

The relative risk of noncervical high‐risk human papillomavirus‐related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population‐based study
por: Loopik, Diede L., et al.
Publicado: (2019)

1049 Evaluating the Population Impact of HPV Vaccine on High Grade Cervical Intraepithelial Neoplasia Rates in an Era of Decreasing Screening
por: Patel, Deven, et al.
Publicado: (2014)

HPV Vaccination in Women Treated for Cervical Intraepithelial Neoplasia: A Budget Impact Analysis
por: Basile, Michele, et al.
Publicado: (2021)

Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route
por: Vo, Trinh Phuong, et al.
Publicado: (2022)

Determinants of HPV-vaccination uptake and subgroups with a lower uptake in the Netherlands
por: de Munter, A. C., et al.
Publicado: (2021)

Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study
por: Ebisch, Renée M. F., et al.
Publicado: (2018)

HPV vaccination of immunocompromised hosts
por: Garland, S.M., et al.
Publicado: (2017)

HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues
por: Stanley, Margaret A, et al.
Publicado: (2012)

Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands
por: Nieuwenhuyzen-de Boer, G. M., et al.
Publicado: (2022)

TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial
por: Koeneman, M. M., et al.
Publicado: (2016)

Perceptions of HPV vaccination and pharmacist-physician collaboration models to improve HPV vaccination rates
por: Teeter, Benjamin S., et al.
Publicado: (2021)

Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial
por: Koeneman, M. M., et al.
Publicado: (2017)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review
por: Bryan, Stacey, et al.
Publicado: (2019)

Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report
por: Sladič, Mateja, et al.
Publicado: (2022)

HPV Vaccination in Women with Cervical Intraepithelial Neoplasia Undergoing Excisional Treatment: Insights into Unsolved Questions
por: Henere, Carla, et al.
Publicado: (2022)

Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge
por: Hoes, J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e4on1au9parneerha4d02ne2an